• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

阿片类药物替代治疗与降低阿片类药物使用障碍患者的死亡风险相关。

Opioid substitution treatment is linked to reduced risk of death in opioid use disorder.

作者信息

Manhapra Ajay, Rosenheck Robert, Fiellin David A

机构信息

VA Hampton Medical Center, Hampton, VA, USA.

Yale School of Medicine, New Haven, CT, USA.

出版信息

BMJ. 2017 Apr 26;357:j1947. doi: 10.1136/bmj.j1947.

DOI:10.1136/bmj.j1947
PMID:28446438
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5412085/
Abstract

Sustained engagement in treatment is vital, particularly in the first “golden month”

摘要

持续参与治疗至关重要，尤其是在首个“黄金月”期间。

相似文献

1
Opioid substitution treatment is linked to reduced risk of death in opioid use disorder.阿片类药物替代治疗与降低阿片类药物使用障碍患者的死亡风险相关。
BMJ. 2017 Apr 26;357:j1947. doi: 10.1136/bmj.j1947.
2
Use and misuse of opioid agonists in opioid addiction.阿片类药物成瘾中阿片类激动剂的使用和滥用。
Cleve Clin J Med. 2017 May;84(5):377-384. doi: 10.3949/ccjm.84a.16091.
3
Predictors of Opioid-Related Death During Methadone Therapy.美沙酮治疗期间阿片类药物相关死亡的预测因素
J Subst Abuse Treat. 2015 Oct;57:30-5. doi: 10.1016/j.jsat.2015.04.008. Epub 2015 Apr 15.
4
Methadone is no panacea.美沙酮并非万灵药。
BMJ. 2012 Aug 22;345:e5670. doi: 10.1136/bmj.e5670.
5
[Levamethadone as substitution treatment of opioid-dependent patients].[左旋美沙酮作为阿片类药物依赖患者的替代治疗]
Dtsch Med Wochenschr. 2013 Oct;138(40):2052-6. doi: 10.1055/s-0033-1349519. Epub 2013 Sep 24.
6
A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).一项关于阿片类药物依赖中睡眠障碍和共病的前瞻性纵向研究（法国国家艾滋病研究机构梅塔维尔研究）
Psychopharmacology (Berl). 2016 Apr;233(7):1203-13. doi: 10.1007/s00213-016-4202-4. Epub 2016 Jan 12.
7
Medicaid Coverage for Methadone Maintenance and Use of Opioid Agonist Therapy in Specialty Addiction Treatment.医疗补助对美沙酮维持治疗的覆盖范围以及阿片类激动剂疗法在专科成瘾治疗中的应用
Psychiatr Serv. 2016 Jun 1;67(6):676-9. doi: 10.1176/appi.ps.201500228. Epub 2016 Feb 29.
8
Buprenorphine and methadone for opioid addiction during pregnancy.孕期阿片类药物成瘾的丁丙诺啡和美沙酮治疗。
Obstet Gynecol Clin North Am. 2014 Jun;41(2):241-53. doi: 10.1016/j.ogc.2014.02.005. Epub 2014 Apr 3.
9
[Better efficacy of buprenorphine and methadone in opioid dependence. Requirements for abstinence from non-opioids before starting treatment paid off].[丁丙诺啡和美沙酮治疗阿片类物质依赖疗效更佳。治疗开始前戒除非阿片类物质的要求取得了成效]
Lakartidningen. 2014;111(5):147-9.
10
Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.在伊朗扩大美沙酮维持治疗，以治疗阿片类药物依赖的囚犯。
Int J Drug Policy. 2010 Sep;21(5):422-4. doi: 10.1016/j.drugpo.2010.03.008. Epub 2010 Apr 21.

引用本文的文献

1
Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada.阿片类药物使用障碍患者阿片类激动剂替代初始剂量治疗的比较效果：一项在加拿大不列颠哥伦比亚省使用目标试验模拟的基于人群的回顾性研究方案
BMJ Open. 2025 Sep 1;15(9):e098990. doi: 10.1136/bmjopen-2025-098990.
2
Emergency department management of opioid use disorder in pediatric patients.儿科患者阿片类物质使用障碍的急诊科管理
J Am Coll Emerg Physicians Open. 2024 Aug 25;5(5):e13265. doi: 10.1002/emp2.13265. eCollection 2024 Oct.
3
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial.抑郁症状严重程度对有处方类阿片使用障碍者丁丙诺啡/纳洛酮和美沙酮治疗结局的影响：一项实用随机对照试验的结果。
J Dual Diagn. 2024 Jul-Sep;20(3):189-200. doi: 10.1080/15504263.2024.2329267. Epub 2024 Apr 5.
4
Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans.VA-BRAVE 研究的原理、设计和方法：一项比较两种丁丙诺啡制剂治疗退伍军人阿片类药物使用障碍的随机对照有效性试验。
Addict Sci Clin Pract. 2022 Jan 31;17(1):6. doi: 10.1186/s13722-022-00286-6.
5
Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration.美国退伍军人事务部（VA）中阿片类药物使用障碍患者的治疗持续时间对死亡率的影响。
Addiction. 2021 Dec;116(12):3494-3503. doi: 10.1111/add.15574. Epub 2021 Jun 1.
6
Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder.一项多中心随机对照试验的设计和方法，该试验评估了长效阿片类物质丁丙诺啡注射与传染病治疗相结合的综合护理模式，对象为因感染和阿片类药物使用障碍住院的患者。
Contemp Clin Trials. 2021 Jun;105:106394. doi: 10.1016/j.cct.2021.106394. Epub 2021 Apr 7.
7
Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada.丁丙诺啡-纳洛酮与美沙酮治疗阿片类物质使用障碍的比较效果：加拿大不列颠哥伦比亚省一项基于人群的观察性研究方案
BMJ Open. 2020 Sep 9;10(9):e036102. doi: 10.1136/bmjopen-2019-036102.
8
Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.阿片类激动剂治疗与阿片类药物过量公共卫生紧急情况下的死亡率之间的关系：基于人群的回顾性队列研究。
BMJ. 2020 Mar 31;368:m772. doi: 10.1136/bmj.m772.
9
Targeting opioid dysregulation in depression for the development of novel therapeutics.针对抑郁症中阿片类物质失调的靶点，开发新的治疗方法。
Pharmacol Ther. 2019 Sep;201:51-76. doi: 10.1016/j.pharmthera.2019.04.009. Epub 2019 Apr 30.
10
Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs.医疗补助限制对成瘾治疗计划中丁丙诺啡供应的影响。
Am J Public Health. 2019 Mar;109(3):434-436. doi: 10.2105/AJPH.2018.304856. Epub 2019 Jan 24.

本文引用的文献

1
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.阿片类药物替代治疗期间及之后的死亡风险：队列研究的系统评价和荟萃分析
BMJ. 2017 Apr 26;357:j1550. doi: 10.1136/bmj.j1550.
2
Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.药物和阿片类药物滥用相关过量死亡人数增加 - 美国，2010-2015 年。
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452. doi: 10.15585/mmwr.mm655051e1.
3
Opioid substitution therapy-time to replace the term.阿片类药物替代疗法——是时候更换这个术语了。
Lancet. 2015 Apr 18;385(9977):1508-9. doi: 10.1016/S0140-6736(15)60750-4.
4
Probability and predictors of treatment-seeking for substance use disorders in the U.S.美国物质使用障碍寻求治疗的概率及预测因素
Drug Alcohol Depend. 2015 Apr 1;149:136-44. doi: 10.1016/j.drugalcdep.2015.01.031. Epub 2015 Feb 9.
5
Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons.美国和英国的处方阿片类药物滥用：警示教训。
Int J Drug Policy. 2014 Nov;25(6):1124-30. doi: 10.1016/j.drugpo.2014.07.009. Epub 2014 Jul 30.
6
Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society.美沙酮安全性：美国疼痛学会、药物依赖问题学会与心律学会合作制定的临床实践指南
J Pain. 2014 Apr;15(4):321-37. doi: 10.1016/j.jpain.2014.01.494.
7
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.丁丙诺啡维持治疗与安慰剂或美沙酮维持治疗用于阿片类物质依赖的比较
Cochrane Database Syst Rev. 2014 Feb 6;2014(2):CD002207. doi: 10.1002/14651858.CD002207.pub4.
8
Remission from substance dependence: differences between individuals in a general population longitudinal survey who do and do not seek help.物质依赖缓解：在一般人群纵向调查中寻求和不寻求帮助的个体之间的差异。
Drug Alcohol Depend. 2013 Nov 1;133(1):146-53. doi: 10.1016/j.drugalcdep.2013.05.019. Epub 2013 Jun 21.
9
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.拯救脓毒症运动：严重脓毒症和脓毒性休克管理国际指南：2012 年。
Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.
10
Oral substitution treatment of injecting opioid users for prevention of HIV infection.对注射阿片类药物使用者进行口服替代治疗以预防艾滋病毒感染。
Cochrane Database Syst Rev. 2011 Aug 10(8):CD004145. doi: 10.1002/14651858.CD004145.pub4.